Literature DB >> 57929

Specific acquired immune unresponsiveness to contact allergens with cyclophosphamide in the mouse.

H C Maguire.   

Abstract

Treatment with cyclophosphamide (Cy) can modulate the acquisition of allergic contact dermatitis in the mouse. We compared the effect of a single dose of Cy given at different times before or after allergen. Cy one or more days prior to allergen intensified, and Cy several days after allergen inhibited the acquisition of sensitivity. Mice whose immunological response to an allergen had been suppressed by Cy were specifically immunologically tolerant to that allergen, but not to an unrelated allergen. This tolerance probably represents a combination of clone deletion and inhibition; almost certainly it does not depend on the generation of enhancing ('blocking') antibody.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57929     DOI: 10.1159/000231543

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.

Authors:  A M Claessen; H Valster; H Bril; S Meyer; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum.

Authors:  D W Roberts; R G Rank; W P Weidanz; J F Finerty
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

3.  Evaluation of various cytostatic drugs as local immunotherapeutic agents.

Authors:  R J Scheper; A Vos; J de Groot; G H Boerrigter
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.

Authors:  G H Boerrigter; R J Scheper
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.